Free Trial
Jan Koch

Jan Koch Analyst Performance

Director, Equity Research at Deutsche Bank Aktiengesellschaft

Jan Koch is a stock analyst at Deutsche Bank Aktiengesellschaft in the medical sector, covering 1 publicly traded companies. Over the past year, Jan Koch has issued 3 stock ratings, including buy and hold recommendations. While full access to Jan Koch's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jan Koch's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 0 Years
Buy Recommendations
66.67% 2 Buy Ratings
Companies Covered
1 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy66.7%2 ratings
Hold33.3%1 ratings
Sell0.0%0 ratings

Out of 3 total stock ratings issued by Jan Koch at Deutsche Bank Aktiengesellschaft, the majority (66.7%) have been Buy recommendations, followed by 33.3% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
100.0% of companies on NYSE
1 company

Jan Koch, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 1 companies listed on , with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
1 company
100.0%

Jan Koch of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
1 company
100.0%

Jan Koch's Ratings History at Deutsche Bank Aktiengesellschaft

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Qiagen N.V. stock logo
QGEN
Qiagen
4/30/2026Reiterated Rating$33.95$43.00Buy
Qiagen N.V. stock logo
QGEN
Qiagen
3/13/2026Upgrade$41.04$54.00Buy
Qiagen N.V. stock logo
QGEN
Qiagen
1/22/2026Downgrade$55.55$54.00Hold